Binding of Actinomycin D to Single-Stranded DNA of Sequence Motifs d(TGTCTnG) and d(TGTnGTCT)  by Chen, Fu-Ming et al.
432 Biophysical Journal Volume 84 January 2003 432–439
Binding of Actinomycin D to Single-Stranded DNA of Sequence Motifs
d(TGTCTnG) and d(TGTnGTCT)
Fu-Ming Chen,* Feng Sha,* Ko-Hsin Chin,y and Shan-Ho Chouy
*Department of Chemistry, Tennessee State University, Nashville, Tennessee 37209 USA and yInstitute of Biochemistry,
National Chung Hsing University, Taichung 40227, Taiwan
ABSTRACT Our recent binding studies with oligomers derived from base replacements on d(CGTCGTCG) had led to the
ﬁnding that actinomycin D (ACTD) binds strongly to d(TGTCATTG) of apparent single-stranded conformation without GpC
sequence. A fold-back binding model was speculated in which the planar phenoxazone inserts at the GTC site with a loop-out T
base whereas the G base at the 39-terminus folds back to form a basepair with the internal C and stacks on the opposite face of
the chromophore. To provide a more concrete support for such a model, ACTD equilibrium binding studies were carried out and
the results are reported herein on oligomers of sequence motifs d(TGTCTnG) and d(TGTnGTC). These oligomers are not
expected to form dimeric duplexes and contain no canonical GpC sequences. It was found that ACTD binds strongly to
d(TGTCTTTTG), d(TGTTTTGTC), and d(TGTTTTTGTC), all exhibiting 1:1 drug/strand binding stoichiometry. The fold-back
binding model with displaced T base is further supported by the ﬁnding that appending TC and TCA at the 39-terminus of
d(TGTCTTTTG) results in oligomers that exhibit enhanced ACTD afﬁnities, consequence of the added basepairing to facilitate
the hairpin formation of d(TGTCTTTTGTC) and d(TGTCTTTTGTCA) in stabilizing the GTC/GTC binding site for juxtaposing the
two G bases for easy stacking on both faces of the phenoxazone chromophore. Further support comes from the observation of
considerable reduction in ACTD afﬁnity when GTC is replaced by GTTC in an oligomer, in line with the reasoning that displacing
two T bases to form a bulge for ACTD binding is more difﬁcult than displacing a single base. Based on the elucidated binding
principle of phenoxazone ring requiring its opposite faces to be stacked by the 39-sides of two G bases for tight ACTD binding,
several oligonucleotide sequences have been designed and found to bind well.
INTRODUCTION
Actinomycin D (ACTD) is an extensively studied antitumor
agent that contains a planar 2-aminophenoxazin-3-one
chromophore and two bulky cyclic pentapeptide lactones
(Fig. 1). It binds to duplex DNA with high afﬁnity and
dissociates slowly, which led to a suggested mechanism
whereby the drug blocks the progression of RNA polymer-
ase along the template DNA and terminates the transcription
(Muller and Crothers, 1968). The DNA binding of ACTD is
quite sequence speciﬁc and has been shown to prefer greatly
the duplex GpC site. This base-sequence speciﬁcity derives
mainly from the formation of strong hydrogen bonds in the
minor groove, between the N-2 amino group and N-3 ring
nitrogen of the two guanine-residues with the carbonyl
oxygen atoms and amide groups of threonine residues of the
cyclic peptapeptides, respectively (Sobell and Jain, 1972;
Kamitori and Takusagawa, 1992). These essential drug-
DNA hydrogen bonds are protected by the cyclic pentapep-
tides, which effectively shield them from solvent exposure. It
is somewhat ironic that the notion of GpC sequence
preference of ACTD has by now been so well established
that it tends to blind-sight the historical fact that this
preference was, in fact, originally proposed based on the
crystal structure of an ACTD-deoxyguanosine complex
(Sobell and Jain, 1972), with both faces of the ACTD
chromophore being stacked by the G bases. The validity of
such a model was subsequently conﬁrmed by optical (Krugh,
1972) as well as NMR (Krugh and Neely, 1973) studies on
dinucleotides in solutions.
Although the GpC sequence-speciﬁcity and the effects of
adjacent bases on the ACTD binding appear to be well
characterized (Chen, 1988; 1992), there have been recent
reports to indicate that this drug may also bind strongly to
some non-GpC-containing sequences (Snyder et al., 1989;
Rill et al., 1989; Bailey et al., 1994) and even to some single-
stranded DNA (Wadkins and Jovin, 1991; Hsieh et al., 1994;
Wadkins et al., 1996; Rill and Hecker, 1996; Wadkins et al.,
1998). In particular, it has been reported that ACTD binds
strongly and cooperatively to a non-GpC-containing but self-
complementary octamer d(CGTCGACG) with a 2:1 drug/
duplex ratio (Snyder et al., 1989). In subsequent studies, our
laboratory found that d(CGTCGTCG) and d(CGACGACG)
also bind strongly to ACTD despite the lack of self-
complementarity (Sha and Chen, 2000). Further studies with
base replacements on d(CGTCGTCG) led us to uncover that
ACTD binds strongly to the sequence d(TGTCATTG) of
apparent single-stranded conformation without GpC sites
(Chen and Sha, 2001). A fold-back binding mode was
speculated for such a binding, wherein the planar phenox-
azone inserts at the GTC site with a loop-out T base whereas
the 39-terminus G folds back to form a basepair with the
internal C and stacks on the opposite face of the chromophore.
Such a ﬁnding is signiﬁcant andmay have relevance inACTD
binding to single-stranded DNA in general. The purpose of
this report is to present evidence to further support such a
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binding model and from which to design other strong ACTD
binding sequences using the delineated binding principle.
Detailed elucidation of ACTD binding to DNA was made
with oligomers of sequence motifs d(TGTCTnG) and
d(TGTnGTCT) that are devoid of GpC sequences and exist
predominantly in single-stranded conformations.
Hairpin model for single-stranded ACTD binding has
been suggested earlier but in quite distinct sequence con-
texts (Rill and Hecker, 1996;Wadkins et al., 1998). For exam-
ple, systematic binding studies of 7-amino-actinomycin D
(7-AM-ACTD) with single-stranded oligomers containing
-TAGT- sequences have led to the suggestion that the drug
binds to metastable hairpins. The hairpins bound most tightly
by ACTD contain non-Watson-Crick basepairs, including
an A/G and two T/T mismatches (Wadkins et al., 1998).
Understanding the ACTD binding to sequences that do not
contain the classic GpC sites should provide considerable
insights into its modes of binding to DNA and assist in
uncovering other new strong binding sequences. Further-
more, studying ligands that bind to single-stranded DNAwith
particular sequence preferences may be of importance in the
regulation of processes that require single-stranded DNA as
intermediates.
MATERIALS AND METHODS
Synthetic oligonucleotides were purchased from Research Genetics (Hunts-
ville, AL) and used without further puriﬁcation. These oligomers were
puriﬁed by the vendor via reverse-phase oligonucleotide puriﬁcation
cartridges and exhibited single-band electrophoretic mobility in denaturing
polyacrylamide gel electrophoresis with stated purity of $95%. Concen-
trations of the DNA solutions (in nucleotide) were determined by measuring
the absorbances at 260 nm after melting (at 958C). The extinction
coefﬁcients of DNA oligomers were obtained via nearest-neighbor
approximation using mono- and dinucleotide values tabulated in Fasman
(1975). ACTD and 7-AM-ACTD were purchased from Sigma (St. Louis,
MO). Concentrations of the drug solutions were determined by measuring
the absorbances at 440 nm (for ACTD) and 528 nm (for 7-AM-ACTD),
using extinction coefﬁcients of 24,500 and 23,600 cm1 M1, respectively.
Stock solutions for oligonucleotides and drugs were prepared by dissolving
in 10 mM Tris-borate buffer solution of pH 8 containing 0.1 M NaCl and 1
mM MgCl2. Absorption spectra were measured with a Cary 1E
spectrophotometric system (Varian, Palo Alto, CA). Absorption spectral
titrations were carried out by starting with a 5 mM ACTD solution of 2 mL
followed by progressive additions of the oligomer stock at equal time
intervals. Absorbance differences between 427 and 480 nm during
absorption spectral titrations were used to obtain the binding isotherms.
The choice of 427 nm is based on the fact that the absorbance change at this
wavelength is slightly larger than that of 440 nm upon DNA binding and that
of the 480 nm is to mimic the baseline value such that the absorbance
differences of two wavelengths should minimize the errors due to baseline
ﬂuctuations during titrations.
Association binding constants (K1) were extracted via nonlinear least-
squares ﬁts on the experimental binding isotherms using 1:1 drug/strand
binding model: D þ S ¼ DS, where D, S, and DS are free drug, free single-
stranded DNA and drug-DNA complex, respectively. By means of equations
for mass balances of drug and DNA (in strand), the following equations can
be derived:
D2K1 þ D½K1DtðX  1Þ þ 1 ¼ Dt
S ¼ DtðX  1Þ þ D
Y ¼ ðeD þ e1K1SÞD=Dt;
where X [ St/Dt, eD, and e1 are the extinction coefﬁcients of the free and
bound drugs, whereas Dt and St are the total drug and DNA strand
concentrations, respectively, at each point of the titration. Experimental
binding isotherms were plotted as the apparent extinction coefﬁcient (Y) vs.
X and nonlinear least-squares ﬁts with the above equations were made to
extract the binding constant K1 and other parameters eD and e1. Nonlinear
least-squares ﬁt program of MicroMath (Salt Lake City, Utah) was used for
our ﬁtting purposes.
RESULTS AND DISCUSSION
ACTD binds strongly to d(TGTCTTTTG),
d(TGTTTTGTCT), and d(TGTTTTTGTCT)
with 1:1 drug/strand binding stoichiometry
Equilibrium binding studies of ACTD were carried out
with oligomers of sequence motifs d(TGTnGTCT) and
d(TGTCTnG). The absence of A base in these oligomers
should reduce possible contributions from dimeric duplex
conformations. Equilibrium binding isotherms for these two
series along with their nonlinear least-squares ﬁtted curves
are shown in Fig. 2. As is apparent from panel A, the ACTD
binding afﬁnity for the d(TGTnGTCT) oligomers increases
progressively as the T-run is increased from 2 to 5. Although
d(TGTGTCT) also exhibits weak ACTD afﬁnity, it is
slightly higher than that of d(TGTTGTCT). It is also quite
evident that ACTD binds avidly to d(TGTTTTTGTCT)
with a binding stoichiometry of 1:1 drug/DNA strand, as
evidenced by the abrupt saturation of the titration curve at
this ratio. Thus, the binding isotherms were ﬁtted with a 1:1
binding model, using nonlinear least-squares method. As can
be seen from the plots, the ﬁts for this series are excellent.
The binding constants extracted from these ﬁts are
summarized in Table 1 for oligomers of both sequence
motifs. The shorter oligomers d(TGTGTCT) and
d(TGTTGTCT) exhibit binding constants of 0.027 3 106
FIGURE 1 The chemical structure of actinomycin D.
Actinomycin D Binding to Non-GpC Hairpins 433
Biophysical Journal 84(1) 432–439
and 0.013 3 106 M1, respectively. The longer oligomers
exhibit considerably stronger ACTD afﬁnities with extracted
binding constants of 1.1 3 106, 7.5 3 106, and 19 3 106
M1 for d(TGTTTGTCT), d(TGTTTTGTCT), and
d(TGTTTTTGTCT), respectively.
The ACTD binding isotherms for oligomers of the
d(TGTCTnG) series are shown in Fig. 2 B. It is immediately
apparent that d(TGTCTG) binds ACTD considerably
weaker than the longer ones. The binding constant for this
oligomer was found to be around 0.01 3 106 M1, whereas
thebindingconstants ford(TGTCTTG),d(TGTCTTTG),and
d(TGTCTTTTG)were found tobe2.8 3 106, 1.1 3 106, and
4.7 3 106 M1, respectively. Except for d(TGTCTTG), its
unusually strong ACTD afﬁnity requires further investiga-
tion, the ACTD afﬁnity of this series also increases as the
number of bases in the T-run is increased. The severalfold
enhancement in ACTD afﬁnity of d(TGTCTTTTG) as
compared to that of d(TGTCTTTG), which in turn is two
orders of magnitude higher than that of d(TGTCTG), is
again consistent with the monomeric fold-back binding
model. Although signiﬁcant ACTD binding strengths ex-
hibited by d(TGTCTTG) is not expected, they may have
their origin in major contributions from sources other than
monomeric hairpin formation.
The stronger ACTD binding exhibited by the oligomers
with longer T-run appears to be in line with our speculated
fold-back binding model, as the propensity for dimeric
duplex formation is low and hairpin formation with 3- to 5-
base loops can easily be formed. A schematic drawing of our
proposed hairpin-binding model as represented by
d(TGTCTTTG) is shown in Fig. 3. The phenoxazone plane
inserts at the GTC site by pushing out the T base and induces
the oligomer to fold back to form a G d C basepair so as to
facilitate stacking of the 39-sides of the two G bases on the
opposite faces of the drug chromophore to form a tight
complex. The weaker ACTD afﬁnities for the shorter oligo-
mers are, thus, partly the consequence of their inability to
form stable drug-induced fold-back complexes.
Binding studies with oligomers derived from
appending bases at the 3’-end of d(TGTCTTTTG)
If the drug induced fold-back to form a G d C basepair
is indeed the mechanism for ACTD binding to
d(TGTCTTTTG), its binding may be affected by base
additions at the 39-terminus, especially by those that can
facilitate the hairpin formation. Binding studies were thus
made with oligomers derived from appending C, AC, and TC
at the 39-end of d(TGTCTTTTG) and their binding
isotherms are compared in Fig. 4 A. The enhanced ACTD
binding afﬁnity due to these additions can clearly be seen,
with the order of enhancement being: d(TGTCTTTTGC) >
d(TGTCTTTTGTC) > d(TGTCTTTTGAC) > d(TGTC-
TTTTG). The extracted binding parameters via nonlinear
least-squares ﬁts with the 1:1 drug/strand binding model are
FIGURE 2 Equilibrium binding isotherms for ACTD binding to
oligomers of d(TGTnGTCT) sequence motif (A) and oligomers of
d(TGTCTnG) sequence motif (B). Absorbance spectral titrations were
carried out at 258C and the absorbance difference DA is that between 427
and 480 nm. Concentrations of both ACTD and DNA (in strand ) are
expressed in mM. Solid curves are those of nonlinear least-squares ﬁts of the
experimental isotherms using the 1:1 drug/strand binding model.
TABLE 1 Comparison of binding and melting parameters for
oligomers of sequence motifs d(TGTnGTCT) and d(TGTnG)
Oligonucleotides K1 (mM1) Tmo (8C) Tm (8C)
d(TGTGTCT) 0.027 6 0.07 24
d(TGTTGTCT) 0.013 6 0.01 25
d(TGTTTGTCT) 1.09 6 0.08 41
d(TGTTTTGTCT) 7.5 6 0.6 55
d(TGTTTTTGTCT) 19 6 6 56
d(TGTCTG) 0.012 6 0.02 27
d(TGTCTTG) 2.8 6 0.2 55
d(TGTCTTTG) 1.1 6 0.2 54
d(TGTCTTTTG) 4.7 6 0.9 55
Equilibrium binding titrations were carried out at 258C and the equilibrium
binding constant K1 is extracted from a nonlinear least-squares ﬁt of the
experimental binding isotherm using the 1:1 drug/strand binding model.
Tm
o and Tm are melting temperatures of 40 mM of DNA/0.1 M NaCl (in
nucleotide) in the absence and in the presence of 7 mM ACTD. Most of the
melting proﬁles for DNA alone are too broad and diffuse for accurate
melting temperature determinations.
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summarized in Table 2 and the results appear to strongly
support the hairpin-binding model. If the ACTD-induced
fold-back of the oligomer is the mechanism for binding,
stronger ACTD binding would be anticipated for
d(TGTCTTTTGC), where one additional G d C basepair
can be formed at the GTC/GC stem of the hairpin to facilitate
the binding site formation as well as to assist in the
displacement of the T base for the ACTD binding. Indeed, a
binding constant of around 100 3 106 M1 was found, a
more than 10-fold increase in the ACTD afﬁnity as compared
to that of d(TGTCTTTTG), with the same 1:1 drug/strand
stoichiometry (Fig. 4 A). By the same reasoning, one would
also expect d(TGTCTTTTGTC) to bind strongly inasmuch
as a GTC/GTC site will also have two G d C basepairs and
the T/T mismatch should facilitate T-base displacements for
ACTD binding. Indeed, a binding constant of 20 3 106 M1
was found with the same binding stoichiometry. This value is
somewhat lower than that of d(TGTCTTTTGC), inasmuch
as the GTC/GC site requires only a single T-base displace-
ment whereas GTC/GTC requires two single-base displace-
ments. If base loop-outs are in fact required for ACTD
binding to the GTC/GTC site, one would anticipate a weaker
afﬁnity at the GTC/GAC site because of the T d A base-
pair formation, which would somewhat hinder such dis-
placements. Indeed, the ACTD binding strength for
d(TGTCTTTTGAC) is found to be 9 3 106 M1, still a
quite sizable value but is about twofold less than that of the
GTC/GTC counterpart. It is also interesting to note that the
ACTD binding afﬁnity for d(TGTCTTTTGTCA) is around
100 3 106 M1 (Table 2), severalfold greater than that
of d(TGTCTTTTGTC). This can be attributed to the added
A d T basepair formation at the duplex ends to further
stabilize the GTC/GTC binding sites.
Studies with the corresponding
GTTC-containing oligomers
If binding at the GTC site requires T-base displacements, one
would expect a weaker binding at the GTTC site because of
the need to displace two T bases in this case, which should be
more difﬁcult than a single-base displacement. Thus, studies
were also made with the corresponding oligomers containing
GTTC instead of GTC and the resulting isotherms are shown
in Fig. 4 B. It is immediately apparent from the proﬁles
that the ACTD afﬁnities are considerably weaker than their
GTC counterparts (compare with Fig. 4 A) but the trend
in binding afﬁnities are similar: d(TGTTCTTTTGC) >
d(TGTTCTTTTGTC) > d(TGTTCTTTTGTTC) >
d(TGTTCTTTTG). The model-ﬁtted binding parameters
are also included in Table 2 for comparison. ACTD binding
constant for d(TGTTCTTTTG) is found to be 0.07 3 106
M1, ;70-fold weaker than that of d(TGTCTTTTG).
However, the addition of a C at the 39-end may result in
the formation of two G d C basepairs with TT-bulge
formation, which should facilitate ACTD binding. Indeed, a
nearly two orders of magnitude enhancement of ACTD
binding afﬁnity is observed with a binding constant of 17 3
106 M1for d(TGTTCTTTTGC). This value, however, is
considerably lower than that of the corresponding oligo-
mer d(TGTCTTTTGC), illustrating the added difﬁculty
FIGURE 3 Schematic drawing of the speculated hairpin-binding model
as represented by d(TGTCTTTG). The rectangle represents the phenox-
azone ring of ACTD.
FIGURE 4 ACTD equilibrium binding isotherms at 258C for oligo-
mers derived by appending 39-terminus of d(TGTCTTTTG) with C, AC,
and TC (A); and for oligomers derived from appending 39-end of
d(TGTTCTTTTG) with C, TC, and TTC (B).
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in forming a two-base bulge. It is also interesting to note
that a binding constant of 3.1 3 106 M1 is observed
for d(TGTTCTTTTGTC), severalfold weaker than
d(TGTTCTTTTGC) as well as d(TGTCTTTTGTC). A
binding constant of 0.47 3 106 M1 is observed for
d(TGTTCTTTTGTTC), which is nearly sevenfold weaker
than that of d(TGTTCTTTTGTC), demonstrating the less
favorable nature of the GTTC/GTTC site as compared to that
of GTTC/GTC GTTC/GC sites. Similar measurements were
also made for oligomers containing -TTT- loops (not shown)
and the results are found to be similar in trend to those of
-TTTT- containing oligomers.
Studies with GC-containing counterparts,
d(TGTnGCT) and d(TGCTnG)
If the speculated binding model is valid for the GTC-
containing oligomers, it should also be applicable to the
corresponding GC-containing sequences because no T-base
displacements will be needed. ACTD binding studies were,
thus, also made with d(TGTnGCT) and d(TGCTnG) se-
quencemotifs and the proﬁles of binding isotherms are shown
in Fig. 5 and the extracted binding parameters are summarized
in Table 3. For the d(TGTnGCT) series (Fig. 5 A), the results
indicate that ACTD binds weakly to d(TGTGCT),
d(TGTTGCT), and d(TGTTTGCT) with respective bind-
ing constants of 0.013 3 106, 0.014 3 106, and 0.06 3
106 M1, but quite well to d(TGTTTTGCT) and d(TG
TTTTTGCT) with binding constants of 4.7 3 106 and
6.2 3 106, respectively. These results support the drug-
induced fold-back binding model with G d C basepair
formation and two G bases stacking on the opposite faces
of the ACTD chromophore.
For the d(TGCTnG) series, the binding order is found to
be: d(TGCTG) ’ d(TGCTTG)  d(TGCTTTG) ’
d(TGCTTTTG), as expected. The extracted binding con-
stants for d(TGCTTTG) and d(TGCTTTTG) are 5.5 3 106
and 3.0 3 106 M1, respectively, an order of magnitude
higher than their shorter counterparts d(TGCTG) and
d(TGCTTG), which exhibit binding constants of 0.33 3
106 and 0.27 3 106 M1, respectively. It should be pointed
out that whereas ACTD binds reasonably well to d(TGC-
TTTG), it binds quite weakly to d(TGTTTGCT) despite the
same number of intervening T bases between GC and G. This
may be rationalized by the fact that the formation of a
G d C basepair via folding-back results in a 3-base T-loop
for the former, whereas it will result in only a 2-base-loop
(with GCT/TGT stem) for the latter, which will likely suffer
considerable strain. The addition of a C base at the 39-
terminus of d(TGCTnG) will result in d(TGCTnGC) which
should considerably facilitate the hairpin formation and will
in turn enhance the ACTD binding. This is indeed the case, as
can be seen from Fig. 5B, where the binding isotherms for the
d(TGCTnGC) series are also included for comparison. It
should also be pointed out in passing that whereas ACTD
binds d(TGTTTGCT) weakly, it binds to d(TGTTTGTCT)
an order of magnitude stronger. The basis for such a dif-
ference, however, is not clear.
TABLE 2 Comparison of binding and melting parameters for
oligomers of various sequences
Oligonucleotides K1 (mM1) Tmo (8C) Tm (8C)
d(TGTCTTTTG) 4.7 6 0.9 55
d(TGTCTTTTGC) >100 30 70
d(TGTCTTTTGAC) 9.0 6 3.5 41 57
d(TGTCTTTTGTC) 20 6 16 65
d(TGTCTTTTGTCA) >100 70
d(TGTTCTTTTG) 0.07 6 0.01 32
d(TGTTCTTTTGC) 17 6 12 47
d(TGTTCTTTTGTC) 3.1 6 0.3 38
d(TGTTCTTTTGTTC) 0.47 6 0.07 29
d(CGTTTTGTG) 1.18 6 0.08 39
d(CCGTTTTGTGG) 10 6 5 47
d(CGTGTTTTGTACG) 18 6 14 34 50
FIGURE 5 ACTD equilibrium binding isotherms at 258C for oligomers
of d(TGTnGCT) motif (A) and for oligomers of d(TGCTnG) and
d(TGCTnGC) motifs (B).
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Designing other strong-binding sequence motifs
To further test and tomake use of the binding principle,ACTD
binding studies were also made with d(CGTTTTGTG),
d(CCGTTTTGTGG), and d(CGTGTTTTGTACG). These
oligomers were designed based on the delineated binding
principle. The increasing presence of the bold-faced comple-
mentary bases at both ends will presumably facilitate the
drug-induced hairpin formation. This should bring theGT/GT
in close proximity to form G d T and T d G mismatches to
create a binding site such that the ACTD chromophore can be
stacked by the 39-sides of the two G bases. A binding
stoichiometry of 1:1 drug/strand would be predicted for these
oligomers, if no additional sites were bound by ACTD. The
binding isotherms of these three oligomers along with that of
d(TGTCTTTG) are compared in Fig. 6. As is apparent, the
ACTD binding afﬁnity of d(CGTTTTGTG) is seen not to
be greatly different from that of d(TGTCTTTG), whereas
d(CCGTTTTGTGG) and d(CGTGTTTTGTACG) exhibit
considerably higher binding propensities with an apparent
1:1 drug/strand binding stoichiometry. Binding constants for
d(CGTTTTGTG), d(CCGTTTTGTGG), and d(CGT-
GTTTTGTACG) were found to be 1.2 3 106, 10 3 106,
and 18 3 106 M1, respectively, which are to be compared
with that of 1.1 3 106 M1 found for d(TGTCTTTG).
The ability to form a 2- or 3-basepaired stem for the stronger
binding oligomers is consistent with the drug-induced
hairpin-binding model.
CONCLUSION
Equilibrium binding studies with oligomers of sequence
motifs d(TGTCTnG) and d(TGTnGTC) have led to the
ﬁnding that ACTD binds strongly to d(TGTCTTTTG),
d(TGTTTTGTC), and d(TGTTTTTGTC), all exhibiting
1:1 drug/strand binding stoichiometry. These oligomers
contain no canonical GpC sequences and are not expected to
form dimeric duplexes. A monomeric binding model was
proposed to account for the strong ACTD afﬁnities of these
oligomers, in which the drug molecule inserts at the GTC site
with a displaced T base while inducing the G base at the
other end to fold back and form a G d C basepair so that the
39-sides of the two G bases can stack on the opposite faces of
the planar phenoxazone chromophore (Fig. 3).
The fold-back binding model with displaced T base is
further supported by the ﬁnding that appending TC or TCA at
the 39-terminus of d(TGTCTTTTG) results in oligomers that
exhibit enhanced ACTD afﬁnity. This may be attributed to
the facilitated hairpin formation of d(TGTCTTTTGTC) and
d(TGTCTTTTGTCA) via extra basepair(s) at the duplex
stem to form the GTC/GTC binding site such that the two G
bases are juxtaposed for easy stacking on both faces of the
phenoxazone chromophore. The identiﬁcation of GTC/GTC
as the binding site and the need for T-base displacements
during ACTD binding are consistent with the ﬁnding that
although the oligomer resulted from adding AC at the 39-end
also exhibits enhanced ACTD binding, its effect is somewhat
less than that of the TC addition. This can be attributed to the
fact that even though the formation of the GTC/GAC site is
facilitated via the hairpin formation of d(TGTCTTTTGAC),
the ACTD binding requires the disruption of the T d A
basepair with subsequent base displacements from the duplex
stem, which is expected to be somewhat more difﬁcult than
that of the GTC/GTC counterpart.
The hairpin-binding model with displaced bases is further
supported by the considerable reduction on ACTD afﬁnity
when GTC in an oligomer is replaced by GTTC. This is in
line with the reasoning that displacing two T bases to form
a bulge for ACTD binding is more difﬁcult than that of a
single-base bulge. The ACTD binding can, however, be
greatly enhanced if GC or GTC is placed at the other end of
the oligomer to facilitate the hairpin formation and to induce
base displacements. Comparative studies with the corre-
TABLE 3 Comparison of binding and melting parameters for
oligomers with GTC replaced by GC
Oligonucleotides K1 (mM1) Tmo (8C) Tm (8C)
d(TGTGCT) 0.013 6 0.008 28
d(TGTTGCT) 0.014 6 0.009 31
d(TGTTTGCT) 0.06 6 0.01 30
d(TGTTTTGCT) 4.7 6 0.8 50
d(TGTTTTTGCT) 6.2 6 0.5 56
d(TGCTG) 0.33 6 0.01 36
d(TGCTTG) 0.27 6 0.03 25
d(TGCTTTG) 5.5 6 0.1 30
d(TGCTTTTG) 3.0 6 0.5 55
d(TGCTTGC) 0.14 6 0.01 37
d(TGCTTTGC) 4.1 6 0.6 26 41
d(TGCTTTTGC) 11.7 6 1.0 33 64
FIGURE 6 ACTD equilibrium isotherms at 258C for d(CGTTTTGTG),
d(CCGTTTTGTGG), and d(CGTGTTTTGTACG). Binding isotherm for
d(TGTCTTTG) is also included for comparison.
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sponding GC-containing oligomers revealed similar binding
stoichiometries to those of their GTC counterparts, further
supporting the proposed hairpin-binding model.
Some interesting comparisons on the binding energetics
areworthy ofmention. For example, the formation of a bulged
T upon ACTD binding to d(TGTCTTTTGC) ($100 mM1)
resulted in a gain of binding free energy by;5.3 kJ/mol from
that of d(TGCTTTTGC) (11.7 mM1), suggesting favorable
contributions from the bulged base on binding. Addition of a
T base to the other GC site resulted in d(TGTCTTTTGTC)
(20 mM1) with the loss of the binding free energy by;4 kJ/
mol from d(TGTCTTTTGC), partly due to the somewhat less
favorableG dC basepair formation in GTC/GTC as compared
to GTC/GC despite the additional T-bulge formation for
binding facilitation. This energy loss, however, can be
regained by appending an A base at the 39-end to form
d(TGTCTTTTGTCA) ($100 mM1) to stabilize the GTC/
GTC site via additional basepair formation. Thus it is clear
that a T-bulge signiﬁcantly enhances ACTD binding, likely
through favorable interactions with the drug. This is further
conﬁrmed by the observation of an avid binding of ACTD to
d(TGCTTTTGTC) ($100 mM1) (data not shown), where
the bulged T is now on the 39- rather than the 59-side. As
to whether the bulged base would be more important for
the quinoid or the benzenoid portion of the chromophore
requires further studies.
The strongest evidence in support of the proposed hairpin-
binding model with base displacements and favorable
contributions from the bulged bases comes from our most
recent NMR study on the ACTD binding to d(GTCACC-
GAC) and d(GGCACCGCC) (Chou et al., 2002). In the
absence of the drug, these oligomers exist as stable hairpins
with ACC loop and 59-GTC/CAG-59 and 59-GGC/CCG-59
duplex stems. In the presence of ACTD, however, they form
DNA-drug complexes with a rather novel intercalation mode.
The central Watson-Crick T/A and G/C basepairs are looped
out and displaced by the ACTD chromophores. The looped-
out bases are not disordered but interact perpendicularly with
the base/chromophore and form speciﬁc hydrogen bonds with
DNA. Such a novel complex structure provides intriguing
insights into how ligands interact with DNA and enlarges the
repertoires for sequence-speciﬁc DNA recognition.
Based on the binding principle of requiring the simulta-
neous stacking of 39-sides of both G bases on the opposite
faces of the planar phenoxazone chromophore, sequences
such as d(CGTTTTGTG), d(CCGTTTTGTGG), and
d(CGTGTTTTGTACG) were designed and tested for their
ACTD binding propensity. Folding back of these oligomers
should result in hairpin formation with duplex stems of 1, 2,
and 3 basepairs, and ACTD molecule is expected to bind at
the GT/GT site with the 39-sides of the two G bases stacking
on the opposite faces of the phenoxazone chromophore.
Stronger ACTD afﬁnities will be expected for those oligo-
mers with easier hairpin-forming propensity. Indeed, d(CGT-
TTTGTG) exhibits only moderately strong ACTD binding
afﬁnity whereas d(CCGTTTTGTGG) and d(CGTGTTTT-
GTACG) exhibit an order of magnitude stronger binding.
Finally, it should also be noted that the strong ACTD
binding to GXC site with bulged X base is not restricted
simply to hairpin motifs, as we have already demonstrated
earlier for some dimeric duplex forming sequences (Chen and
Sha, 2002). By regarding ACTD to prefer having the 39-sides
of two G bases stacked on the opposite faces of its planar
phenoxazone, one has greatly expanded the repertoire of this
drug. The classic duplex GpC sequence preference of ACTD
can, thus, be simply viewed as the consequence of
accomplishing such a juxtaposition of the G bases via G d C
basepair formation.
Research supported by a subproject of Minority Biomedical Research
Support grant S06GM0892.
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